MARKET

MTRI

MTRI

Mentari Therapeutics Inc
NASDAQ
16.00
+0.44
+2.83%
After Hours: 15.00 -1 -6.25% 19:56 11/09 EST
OPEN
14.80
PREV CLOSE
15.56
HIGH
16.96
LOW
12.34
VOLUME
54.29K
TURNOVER
--
52 WEEK HIGH
23.30
52 WEEK LOW
5.75
MARKET CAP
87.90M
P/E (TTM)
-5.3036
1D
5D
1M
3M
1Y
5Y
1D
Press Release: Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing
Dow Jones · 17h ago
Press Release: Mentari Therapeutics Announces -2-
Dow Jones · 17h ago
Weekly Report: what happened at INM last week (1102-1106)?
Weekly Report · 20h ago
*InMed Pharmaceuticals: Mentari Therapeutics Shares Expected to Begin Trading on Nasdaq Capital Market Under Symbol MTRI Starting Nov. 9>INM
Dow Jones · 3d ago
*InMed Pharmaceuticals Completes Closing Of Merger With Mentari Therapeutics >INM
Dow Jones · 3d ago
Press Release: InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics
Dow Jones · 3d ago
InMed Pharmaceuticals Inc. Announces Name Change to Mentari Therapeutics, Inc. and Share Consolidation
NASDAQ · 4d ago
InMed expects to start trading as Mentari Therapeutics on November 9
TipRanks · 4d ago
More
About MTRI
Mentari Therapeutics, Inc., formerly InMed Pharmaceuticals Inc., is a biotechnology company developing therapies for migraine prevention. The Company's lead programs target PACAP, a newly validated target that is mechanistically independent from calcitonin gene-related peptide (CGRP). Its pipeline includes MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing, and MT-002, an anti-CGRP and anti-PACAP bispecific antibody designed to inhibit these complementary pathways with the potential to deliver superior outcomes for people with incomplete response to CGRP-targeted therapies.

Webull offers Mentari Therapeutics, Inc. stock information, including NASDAQ: MTRI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTRI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MTRI stock methods without spending real money on the virtual paper trading platform.